Effects of Fructooligofructoses Chain Length on the Bifidobacteria of the Human Colon: A Pilot Study

Krista Mendlik, Julie A. Albrecht, Marilynn Schnepf

Department of Nutrition and Health Sciences, University of Nebraska—Lincoln, Lincoln, USA.

DOI: 10.4236/fns.2012.312211                

Abstract

Human gastrointestinal health may be improved by the consumption of prebiotic food ingredients such as fructooligo-fructoses. A study was initiated to determine the effect of fructooligofructoses of different chain lengths on gastrointes-tinal parameters. Nineteen healthy subjects aged 20 - 57 y took part in a 10-week cross-over designed study. Subjects consumed either inulin or oligofructose for 3 weeks followed by a 2-week washout period between treatments. Stool samples were collected five times (baseline, 2 treatments, 2 washout) and analyzed for bifidobacteria. Daily records were kept for stool frequency, stool consistency and flatulence frequency. Bifidobacteria counts (cfu/ml) were higher (trending toward significance) during inulin and oligofructose intakes (1.2 × 10⁷ ± 4.8 × 10⁷ and 2.0 × 10⁸ ± 4.7 × 10⁸) and washout periods (2.9 × 10⁶ ± 6.5 × 10⁶ and 1.1 × 10⁷ ± 1.6 × 10⁷) than baseline counts (2.2 × 10⁵ ± 5.1 × 10⁵ and 2.9 × 10⁶ ± 6.5 × 10⁶), respectively. Inulin and oligofructose treatment periods had a significant effect on stool consistency (watery/very hard) and flatulence frequency, but not stool frequency, when compared to baseline (P < 0.05). Further research is needed to confirm these results due to small sample size and the need for a longer washout period between treatments.

Keywords

Prebiotics; Fructooligofructoses; Inulin; Oligofructose; Bifidobacteria

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	S. Kolida and G. R. Gibson, “Prebiotic Capacity of Inu-lin-Type Fructans,” Journal of Nutrition, Vol. 137, No. S 11, 2007, pp. S2503-S2506.
[2]	J. M. W. Wong and D. J. Jenkins, “Carbohydrate Digesti-bility and Metabolic Effects,” Journal of Nutrition, Vol. 137, No. S11, 2007, pp. S2539-S2546.
[3]	G. R. Gibson and X. Wang, “Regulatory Effects of Bifidobacteria on the Growth of Other Colonic Bacteria,” Journal of Applied Bacteriology, Vol. 77, No. 4, 1994, pp. 412-420. doi:10.1111/j.1365-2672.1994.tb03443.x
[4]	G. R. Gibson and A. L. McCartney, “Modification of the Gut Flora by Dietary Means,” Biochemical Society Transactions, Vol. 26, No. 2, 1998, pp. 222-228.
[5]	G. R. Gibson and M. R. Roberfroid, “Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics,” Journal of Nutrition, Vol. 125, No. 6, 1995, pp. 1401-1412.
[6]	B. Kleesen, B. Sykura, H. J. Zunft and M. Blaut, “Effects of Inulin and Lactose on Fecal Microflora, Microbial Activity, and Bowel Habit in Elderly Constipated Persons,” The American Journal of Clinical Nutrition, Vol. 65, No. 5, 1997, pp. 1397-1402.
[7]	M. B. Roberfroid, “Functional Effects of Food Components and the Gastrointestinal System: Chicory Froctoologosaccharides,” Nutrition Reviews, Vol. 54, No. 11, 1996, pp. S38-S42. doi:10.1111/j.1753-4887.1996.tb03817.x
[8]	M. M. Amann, M. J. Kullen, M. C. Martini, F. F. Busta and L. J. Brady, “Consumption of Exogenous Bifidobacteria does not Alter Fecal Bifidobacteria and Breath Hydrogen Excretion in Humans,” Journal of Nutrition, Vol. 128, No. 6, 1998, pp. 996-1002.
[9]	X. Wang and G. R. Gibson, “Effects of the in-Vitro Fermentation of Oligofructose and Inulin by Bacterial Growing in the Human Large Intestine,” Journal of Applied Bacteriology, Vol. 75, No. 4, 1993, pp. 373-380. doi:10.1111/j.1365-2672.1993.tb02790.x
[10]	M. B. Roberfriod, J. A. Van Loo and G. R. Gibson, “The Bifidogenic Nature of Chicory Inulin and Its Hydrolysis Products,” Journal of Nutrition, Vol. 128, No. 1, 1998, pp. 11-19.
[11]	S. Perrin, C. Foufnies, J. P. Grill, H. Jacobs and F. Schneider, “Fermentation of Chicory Fructo-Oligofructoses in Mixtures of Different Degrees of Polymerization by Three Strains of Bifidobactreria,” Canadian Journal of Microbiology, Vol. 48, No. 8, 2002, pp. 759-763. doi:10.1139/w02-065
[12]	G. R. Gibson and X. Wang, “Bifidogenic Properties of Different Types of Fructo-Oligofructoses,” Food Microbiology, Vol. 11 No. 6, 1994. pp. 491-498. doi:10.1006/fmic.1994.1055
[13]	M. Rossi, C. Corradini, A. Amaretti, M. Nicolini, A. Pompei, S. Zanoni and D. Matteuzzi, “Fermentation of Fructoologosaccharides and Inulin by Bifidobacteria: A Comparitive Study of Pure and Fecal Cultures,” Applied and Environmental Microbiology, Vol. 71, No. 10, 2005, pp. 6150-6158. doi:10.1128/AEM.71.10.6150-6158.2005
[14]	Y. Bouhnik, B. Flourie, C. Andrieux, N. Bisetti, F. Briet and J.-C. Rambaud, “Effects of Bifidobacterium sp Fermented Milk Ingested with or without Inulin Colonic Bifidobacteria and Enzymatic Activities in Healthy Humans,” European Journal of Clinical Nutrition, Vol. 50, No. 10, 1996, pp. 267-273.
[15]	Y. Bouhnik, B. Flourie, L. A’Gay-Abensour, P. Pochart, G. Gramlet, M. Durland and J-C. Rambaud, “Administration of Transgalacto-Oligofructoses Increased Fecal Bifidobacteria and Modifies Colonic Fermentation Metabolism in Health Humans,” Journal of Nutrition, Vol. 127, No. 3, 1997, pp. 444-448.
[16]	J. O. Hunter, Q. Tuffnell and A. J. Lee, “Controlled Trial of Oligofructose in the Management of Irritable Bowel Syndrome,” Journal of Nutrition, Vol. 129, No. S7, 1999, pp. S1451-S1453.
[17]	E. Menne, N. Guggenbuhl and M. Roberford, “Fn-Type Chicory Inulin Hydrolysate had a Prebiotic Effect in Humans,” Journal of Nutrition, Vol. 130, No. 5, 2000, pp. 1197-1199.
[18]	H.-P. Kruse, B. Kleesen and M. Blaut, “Effects of Inulin on Faecal Bifidobacteria in Human Subjects,” British Journal of Nutrition, Vol. 82. No. 5, 1999, pp. 375-382.
[19]	F. J. Munoa and R. Pares, “Selective Medium for Isolation and Enumeration of Bifidobacterium spp,” Applied and Environmental Microbiology, Vol. 54, No. 7, 1988, pp. 1715-1718.
[20]	SPSS, Version 14.0 for Windows, SPSS, Inc., Chicago.
[21]	Y. Bouhnik, K. Vahedi, L. Achour, A. Attar, J. Salfati, P. Pochar, P. Marteau, B. Flourie, F. Bornet and J.-C. Rambaud, “Short-Chain Fructo-Oligosaccharide Administration Dose-Dependently Increases Fecal Bifidobacteria in Healthy Humans,” Journal of Nutrition, Vol. 129, No. 1, 1999, pp. 113-116.